EQUUS TOTAL RETURN, INC. (NYSE:EQS) Files An 8-K Other Events
Item 8.01 Other Events.
On June 12, 2017, the Equus Total Return, Inc. issued a press
release announcing the repayment of its loan to Biogenic
Reagents, LLC. The text of the press release is included as
Exhibit 99.1 to this Current Report and is incorporated herein by
Item 9.01 Financial Statements and Exhibits.
99.1 Press release issued on June 12, 2017 by Equus Total Return,
About EQUUS TOTAL RETURN, INC. (NYSE:EQS)
Equus Total Return, Inc. (the Fund) is a closed-end management investment company. The Fund is a business development company whose investment objective is to maximize the total return to its stockholders in the form of current investment income and long-term capital gains by investing in the debt and equity securities of small and middle market capitalization companies that are generally not publicly traded at the time of its investment. In addition, it may invest with other co-investors, including private equity firms, business development companies, small business investment companies, venture capital groups, institutional investors and individual investors. It invests in a range of sectors, including energy, media, business products and services, shipping products and services, financial services and others. The Fund’s investments in portfolio securities consist of fixed-rate debt securities, limited liability company investments, common stock, and secured and subordinated debt.